Osaka City General Hospital

Osaka, Osaka 5340021

1 studies enrolling now · 10 studies all time

What they study most

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, Atherosclerotic Cardiovascular Disease, Colitis, Ulcerative, Crohn's Disease, Dravet Syndrome (DS), KRAS p, G12c Mutated /Advanced Metastatic NSCLC, Lennox Gastaut Syndrome (LGS), Locally Advanced Solid Tumors, Metastatic Solid Tumors, Non-small Cell Lung Cancer

Studies at this site

• A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements — Recruiting now
• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling
• Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200). — Completed
• A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome — Stopped early
• Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05) — Completed
• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
• A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
• A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease — Completed
• A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome — Completed
• A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome — Completed